Receptors, Mineralocorticoid
"Receptors, Mineralocorticoid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cytoplasmic proteins that specifically bind mineralocorticoids and mediate their cellular effects. The receptor with its bound ligand acts in the nucleus to induce transcription of specific segments of DNA. Mineralocorticoids were named for their actions on extracellular electrolyte concentrations. The most important example is aldosterone.
MeSH Number(s)
D12.776.260.698.750.530
D12.776.826.750.530
D12.776.930.669.750.530
Concept/Terms
Receptors, Mineralocorticoid- Receptors, Mineralocorticoid
- Mineralocorticoid Receptors
- Mineralocorticoid Receptor
- Receptor, Mineralocorticoid
- Receptors, Mineralocorticoids
- Mineralocorticoids Receptors
Receptors, Corticoid Type I- Receptors, Corticoid Type I
- Corticoid Type I Receptors
- Corticoid I Receptor
- Receptor, Corticoid I
- Receptors, Corticoid I
- Corticoid I Receptors
Below are MeSH descriptors whose meaning is more general than "Receptors, Mineralocorticoid".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- DNA-Binding Proteins [D12.776.260]
- Receptors, Cytoplasmic and Nuclear [D12.776.260.698]
- Receptors, Steroid [D12.776.260.698.750]
- Receptors, Mineralocorticoid [D12.776.260.698.750.530]
- Receptors, Cytoplasmic and Nuclear [D12.776.826]
- Receptors, Steroid [D12.776.826.750]
- Receptors, Mineralocorticoid [D12.776.826.750.530]
- Transcription Factors [D12.776.930]
- Receptors, Cytoplasmic and Nuclear [D12.776.930.669]
- Receptors, Steroid [D12.776.930.669.750]
- Receptors, Mineralocorticoid [D12.776.930.669.750.530]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Mineralocorticoid".
This graph shows the total number of publications written about "Receptors, Mineralocorticoid" by people in Harvard Catalyst Profiles by year, and whether "Receptors, Mineralocorticoid" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 2 | 1 | 3 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 3 | 4 |
| 2011 | 7 | 1 | 8 |
| 2012 | 3 | 1 | 4 |
| 2013 | 2 | 1 | 3 |
| 2014 | 2 | 2 | 4 |
| 2015 | 4 | 0 | 4 |
| 2016 | 0 | 1 | 1 |
| 2017 | 3 | 2 | 5 |
| 2018 | 2 | 1 | 3 |
| 2019 | 3 | 1 | 4 |
| 2020 | 1 | 0 | 1 |
| 2021 | 2 | 2 | 4 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 3 | 3 |
Below are the most recent publications written about "Receptors, Mineralocorticoid" by people in Profiles.
-
Effects of Mineralocorticoid Receptor Blockade and Statins on Kidney Injury Marker 1 (KIM-1) in Female Rats Receiving L-NAME and Angiotensin II. Int J Mol Sci. 2023 Mar 30; 24(7).
-
Early Implementation of Aldosterone-Targeted Therapy in Patients With Hypertension. Circulation. 2023 Mar 28; 147(13):991-992.
-
Smooth Muscle Mineralocorticoid Receptor Promotes Hypertension After Preeclampsia. Circ Res. 2023 03 17; 132(6):674-689.
-
Aldosterone in chronic kidney disease and renal outcomes. Eur Heart J. 2022 10 11; 43(38):3781-3791.
-
Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease. Eur Heart J. 2022 08 14; 43(31):2931-2945.
-
Myeloid Mineralocorticoid Receptor Transcriptionally Regulates P-Selectin Glycoprotein Ligand-1 and Promotes Monocyte Trafficking and Atherosclerosis. Arterioscler Thromb Vasc Biol. 2021 11; 41(11):2740-2755.
-
Striatin genotype-based, mineralocorticoid receptor antagonist-driven clinical trial: study rationale and design. Pharmacogenet Genomics. 2021 06 01; 31(4):83-88.
-
Mineralocorticoid receptors dampen glucocorticoid receptor sensitivity to stress via regulation of FKBP5. Cell Rep. 2021 06 01; 35(9):109185.
-
Finerenone: A Non-steroidal Mineralocorticoid Receptor Blocker for Diabetic Kidney Disease. Trends Endocrinol Metab. 2021 05; 32(5):261-263.
-
Lysine-Specific Demethylase-1 Deficiency Increases Agonist Signaling Via the Mineralocorticoid Receptor. Hypertension. 2020 04; 75(4):1045-1053.